作者:Iain R. Greig、Emmanuel Coste、Stuart H. Ralston、Rob J. van’t Hof
DOI:10.1016/j.bmcl.2010.07.055
日期:2010.9
Biphenylketones were identified as novel inhibitors of NF kappa B activation. Structure-activity studies led to the identification of compound 4c, which had good potency against osteoclasts (IC(50) = 0.8 mu M), showed oral activity, and was able to completely prevent inflammation and bone loss in vivo. (C) 2010 Elsevier Ltd. All rights reserved.